Patent ID: 8318744
Filing Date: 2012-11-27
Classification: A61K,A61P,C07D

Abstract:
1. A compound which is 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine hydrochloride anhydrate in crystalline modification III (Form III) having at least five characteristic peaks selected from the 2Theta values corresponding to 5.82 ±0.1, 11.00 ±0.1, 14.89 ±0.1, 16.96 ±0.1, 17.41 ±0.1, 17.97 ±0.1, 21.16 ±0.1, 22.05 ±0.1, 25.28 ±0.1 and 28.03 ±0.1 degrees.